{"Alpha 1 foetoprotein increased": 117.58745308698218, "Ascites": 5.550053398271658, "Blister": 3.4120996548188627, "Diarrhoea": 3.3407404264033818, "Disease progression": 5.839117538334553, "Drug ineffective for unapproved indication": 6.258355117317848, "Erythema multiforme": 5.510979238909851, "Haematotoxicity": 11.741519357162655, "Hepatic encephalopathy": 10.293247755647284, "Hepatic failure": 6.0591430036270655, "Hepatocellular carcinoma": 45.14421136202953, "Hepatotoxicity": 5.478867204588851, "Hyperkeratosis": 18.3733643542266, "Hypertension": 3.013407366915988, "Hypocalcaemia": 9.6470695970997, "International normalised ratio increased": 2.1038195462158686, "Malignant neoplasm progression": 2.809789132493224, "Metastases to adrenals": 69.905760963194, "Metastases to bone": 8.459648334480317, "Metastases to liver": 6.502514645388471, "Metastases to lung": 30.543054872294285, "Metastatic renal cell carcinoma": 30.86796027671447, "Mucosal inflammation": 8.28979992726653, "Neoplasm progression": 3.452534897166229, "Off label use": 5.293977606675179, "Osteonecrosis of jaw": 14.70981260897226, "Palmar-plantar erythrodysaesthesia syndrome": 71.92652538146406, "Product use in unapproved indication": 7.835363440653246, "Rash maculo-papular": 2.776626436271433, "Renal cell carcinoma": 15.910019249109528, "Skin exfoliation": 2.8192660283382813, "Skin reaction": 4.758319618050393, "Skin toxicity": 48.99359915368554, "Skin ulcer": 6.50701368486814, "Squamous cell carcinoma of skin": 28.353003645537928, "Stevens-Johnson syndrome": 4.156051349482739, "Thrombocytopenia": 3.780902588912728, "Tumour lysis syndrome": 15.731632606322991, "Weight decreased": 2.306152531961974}